Clinical trials
Terminated Uterine Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2006 | 5 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 5 |
| Precision Therapeutics | 2 |
| Dick Domanik | 1 |
| Elevation Oncology | 1 |
| Genmab | 1 |
| Mark H. Einstein | 1 |
| New Mexico Cancer Research Alliance | 1 |
| Nghi Nguyen | 1 |
| Pfizer | 1 |
| Shasqi, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Neoplasms | 21 |
| Ovarian Neoplasms | 9 |
| Endometrial Neoplasms | 4 |
| Urinary Bladder Neoplasms | 4 |
| Uterine Cervical Neoplasms | 4 |
| Esophageal Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Recurrence | 3 |
| Sarcoma | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.